Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GI-HOPE: Inhaled Molgramostim for Pneumonia-Associated ARDS
NCT02595060Phase 2Completed
- Sponsor
- Justus Liebig University Giessen
- Start
- Jun 2016
- Primary completion
- Sep 2021
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of molgramostim in acute respiratory distress syndrome (ARDS), sponsored by Justus Liebig University Giessen. Started Jun 2016; status: completed.
02
Drugs
molgramostim
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT02595060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02595060.